Tag: intracept
Boston announces clinical data from chronic pain portfolio at ASPN 2024
Boston Scientific Corporation has announced the presentation of positive five-year pooled results for the Intracept intraosseous nerve ablation system, measuring outcomes across three clinical...
Boston Scientific expands neuromodulation portfolio with Relievant Medsystems acquisition
Boston Scientific Corporation has announced the close of its acquisition of Relievant Medsystems—the company behind the US Food and Drug Administration (FDA)-cleared Intracept intraosseous...
Boston Scientific to expand neuromodulation portfolio with Relievant Medsystems acquisition
Boston Scientific Corporation has today announced it has entered into a definitive agreement to acquire Relievant Medsystems—a privately held medical technology company that has...
